다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Fusion Pharmaceuticals Inc (FUSN)
Fusion Pharmaceuticals Inc (FUSN) 뉴스

FUSN

Fusion Pharmaceuticals (FUSN)

Fusion Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FUSN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/01	05:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/06/01	05:05	PR Newswire (US)	Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/06/01	05:05	PR Newswire (Canada)	Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/30	05:34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/30	05:05	PR Newswire (Canada)	Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/30	05:05	PR Newswire (US)	Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/11	05:15	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/10	20:54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/10	05:14	PR Newswire (US)	Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/10	05:14	PR Newswire (Canada)	Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/07	21:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/07	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/07	20:00	PR Newswire (US)	Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/05/07	20:00	PR Newswire (Canada)	Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/04/27	02:56	PR Newswire (US)	Kuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to Contact Law Firm	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/04/26	05:34	PR Newswire (US)	Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/04/26	05:34	PR Newswire (Canada)	Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/04/10	05:05	PR Newswire (US)	Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/04/10	05:05	PR Newswire (Canada)	Fusion Pharmaceuticals Announces Presentation of Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the AACR Annual Meeting 2024	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/21	05:10	PR Newswire (US)	Kuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to Contact Law Firm	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/21	05:05	PR Newswire (Canada)	Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/21	05:05	PR Newswire (US)	Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/19	16:00	PR Newswire (US)	Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/19	16:00	PR Newswire (Canada)	Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/06	21:45	PR Newswire (US)	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/06	21:45	PR Newswire (Canada)	Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/06	06:43	PR Newswire (Canada)	Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual Meeting	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/03/06	06:43	PR Newswire (US)	Fusion Pharmaceuticals to Present Interim Data from the Phase 2 TATCIST Clinical Trial Evaluating FPI-2265 at the 2024 AACR Annual Meeting	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/02/26	21:45	PR Newswire (Canada)	Fusion Pharmaceuticals to Present at Upcoming March Investor Conferences	NASDAQ:FUSN	Fusion Pharmaceuticals Inc
2024/02/26	21:45	PR Newswire (US)	Fusion Pharmaceuticals to Present at Upcoming March Investor Conferences	NASDAQ:FUSN	Fusion Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:FUSN

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

US Dollar vs Sterling

JP Morgan Chase

Financial Select Sector

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관